Nutriband Inc., a developer of prescription transdermal pharmaceutical products, has completed the commercial manufacturing process scale-up for Aversa Fentanyl, in collaboration with Kindeva, a CDMO focused on drug-device combination products. Aversa Fentanyl combines Nutriband’s Aversa abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch. Aversa Fentanyl is manufactured at Kindeva’s transdermal manufacturing facility in the U.S.  Aversa Fentanyl has the potential to...